Invesco
PEAR

Invesco’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Invesco’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,161
Closed -$4.12K – 4040
2023
Q1 		$4.12K Sell
16,161
-759
-4% -$686 ﹤0.01% 3858
2022
Q4 		$20K Sell
16,920
-1,246
-7% -$2.62K ﹤0.01% 3971
2022
Q3 		$38K Buy
+18,166
New +$30.8K ﹤0.01% 3938

Invesco's PEAR Position: Q2 2023 in Review

Invesco sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 16,161 shares — an estimated $4.12K sold.

Invesco first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $38K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • Invesco reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Invesco sold 16,161 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $4.12K.
  • Invesco first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • Invesco's Pear Therapeutics, Inc. Class A Common Stock position peaked at $38K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.